|
ZNF432 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.67055258515347E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.38680203274089E-11 |
| Normal-vs-Stage2 |
7.74300000006001E-07 |
| Normal-vs-Stage3 |
1.50369716678256E-11 |
| Normal-vs-Stage4 |
1.93839999607093E-09 |
| Stage1-vs-Stage2 |
7.858400E-01 |
| Stage1-vs-Stage3 |
1.193010E-01 |
| Stage1-vs-Stage4 |
1.117830E-01 |
| Stage2-vs-Stage3 |
4.114600E-01 |
| Stage2-vs-Stage4 |
3.641200E-01 |
| Stage3-vs-Stage4 |
8.662400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.80659997651401E-13 |
| Normal-vs-AfricanAmerican |
3.244200E-03 |
| Normal-vs-Asian |
1.94960000365896E-08 |
| Caucasian-vs-AfricanAmerican |
1.982650E-01 |
| Caucasian-vs-Asian |
6.367600E-01 |
| AfricanAmerican-vs-Asian |
1.389590E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.73700054340031E-10 |
| Normal-vs-Female |
2.01394456667003E-12 |
| Male-vs-Female |
9.038600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.46079999710602E-08 |
| Normal-vs-Age(41-60Yrs) |
4.91120477619233E-11 |
| Normal-vs-Age(61-80Yrs) |
1.77389991584675E-10 |
| Normal-vs-Age(81-100Yrs) |
1.366200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.328600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.738800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.235400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.018000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.753800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.754600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.754900E-04 |
| Classical-VS-Follicular |
4.556300E-02 |
| Classical-VS-Other |
6.784000E-01 |
| Classical-VS-Normal |
1.65019999998073E-07 |
| Tall-VS-Follicular |
1.694620E-01 |
| Tall-VS-Other |
4.153000E-01 |
| Tall-VS-Normal |
5.71940272919846E-11 |
| Follicular-VS-Other |
8.153400E-01 |
| Follicular-VS-Normal |
2.40989994626517E-09 |
| Other-VS-Normal |
1.408280E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.64159796867125E-11 |
| Normal-vs-N1 |
4.74240002823478E-09 |
| N0-vs-N1 |
5.006200E-01 |
|
|
